[PDF][PDF] The origin of SARS-CoV-2 in Istanbul: Sequencing findings from the epicenter of the pandemic in Turkey.

…, J Yildiz, B Kose, AS Ozel, LN Altunal… - Northern Clinics of …, 2020 - jag.journalagent.com
OBJECTIVE: Turkey is one of the latest countries that COVID-19 disease was reported, with
the first case on March 11, 2020, and since then, Istanbul became the epicenter of the …

Combined metabolic cofactor supplementation accelerates recovery in mild-to-moderate COVID-19

O Altay, H Yang, M Aydin, G Alkurt, LN Altunal, W Kim… - MedRxiv, 2020 - medrxiv.org
BACKGROUND The characteristics of COVID-19 outbreak and high fatality rate of COVID□19
infection have attracted the attention of scientists due to the strong interactions between …

Changes in antimicrobial resistance and outcomes of health care–associated infections

…, A Asan, HTE Mert, Z Yulugkural, LN Altunal… - European Journal of …, 2021 - Springer
To describe the change in the epidemiology of health care–associated infections (HAI),
resistance and predictors of fatality we conducted a nationwide study in 24 hospitals between …

Prognostic value of inflammatory biomarkers in patients with severe COVID-19: A single-center retrospective study

G Açıksarı, M Koçak, Y Çağ, LN Altunal… - Biomarker …, 2021 - journals.sagepub.com
Background: The current knowledge about novel coronavirus-2019 (COVID-19) indicates
that the immune system and inflammatory response play a crucial role in the severity and …

Safety and immunogenicity of inactive vaccines as booster doses for COVID-19 in Türkiye: A randomized trial

…, O Karakas, S Gokdemir, LN Altunal… - Human Vaccines & …, 2022 - Taylor & Francis
Protective neutralizing antibody titers reduce in time after COVID-19 vaccinations, as in
individuals who have had COVID-19. This study aimed to evaluate the safety and …

Prevalence of Polypharmacy and Potential Drug–Drug Interactions Associated with Risk Factors in the Era of HIV Integrase Inhibitors: A Prospective Clinical Study

LN Altunal, D Yagcı Caglayık, AS Ozel… - AIDS Patient Care …, 2023 - liebertpub.com
People living with human immunodeficiency virus (PLWH), with the availability of modern
antiretroviral drugs, have multiple comorbidities, which increase the risk of polypharmacy and …

[PDF][PDF] Appropriate Use of Tocilizumab in COVID-19: Early Use is Beneficial

LN Altunal, M Aydın, AS Özel, G Çam - Infectious Diseases & …, 2022 - idcmjournal.org
Objective: Interleukin-6 inhibitor Tocilizumab (TCZ) is effective to prevent the mortality of
severe COVID-19 by suppressing the cytokine storm, however, its appropriate use needs to be …

Long-Term Results of Immunogenicity of Booster Vaccination against SARS-CoV-2 (Hybrid COV-RAPEL TR Study) in Turkiye: A Double-Blind, Randomized …

…, SC Guven, O Karakas, S Gokdemir, LN Altunal… - Vaccines, 2023 - mdpi.com
The immunogenicity of vaccines decreases over time, causing a need for booster doses.
This study aimed to present the long-term (Day 84) immunogenicity results of the double-blind, …

Evaluation of modified ATRIA risk score in predicting mortality in hospitalized patients with COVID-19

…, G Cetinkal, M Kocak, Y Cag, A Atici, LN Altunal… - The American journal of …, 2021 - Elsevier
… Author links open overlay panel Gonul Aciksari 1 , Gokhan Cetinkal 2 , Mehmet Kocak 3 ,
Yasemin Cag 4 , Adem Atici 1 , Lutfiye Nilsun Altunal 5 , Hasan Ali Barman 6 , Mehtap Aydin 5 , …

Cytomegalovirus Reactivation in Ulcerative Colitis Patients: Early Indicators

LN Altunal, AS Ozel, C Ak - Nigerian Journal of Clinical Practice, 2023 - ajol.info
Background: The association of cytomegalovirus (CMV) infection with ulcerative colitis (UC)
still remains a controversial topic for the clinicians. Aim: In this study, we aimed to elucidate …